PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31489998-0	2020	Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering Wnt signaling.	Paclitaxel	100-110	guanylate binding protein 2	Homo sapiens	0-27	
31489998-0	2020	Guanylate-binding protein-2 inhibits colorectal cancer cell growth and increases the sensitivity to paclitaxel of paclitaxel-resistant colorectal cancer cells by interfering Wnt signaling.	Paclitaxel	114-124	guanylate binding protein 2	Homo sapiens	0-27	
31489998-4	2020	In this study, the authors are determined to dig into the role that GBP-2 plays in the sensitivity of CRC to PTX, therefore, possibly indicating a promising gene therapy target for CRC.	Paclitaxel	109-112	guanylate binding protein 2	Homo sapiens	68-73	
31489998-8	2020	The level of GBP-2 mRNA and protein in PTX-resistant CRC cell lines was significantly lower than in nonresistant cell lines.	Paclitaxel	39-42	guanylate binding protein 2	Homo sapiens	13-18	
31489998-9	2020	Forced exogenous expression of GBP-2 in PTX-resistant CRC cell lines resulted in more sensitivity to PTX because of the demonstration of less cell proliferation, invasion, and more apoptosis.	Paclitaxel	40-43	guanylate binding protein 2	Homo sapiens	31-36	
31489998-9	2020	Forced exogenous expression of GBP-2 in PTX-resistant CRC cell lines resulted in more sensitivity to PTX because of the demonstration of less cell proliferation, invasion, and more apoptosis.	Paclitaxel	101-104	guanylate binding protein 2	Homo sapiens	31-36	
31489998-11	2020	GBP-2 upregulation could enhance the killing effect of PTX in both PTX-sensitive CRC cells and PTX-resistant CRC cells by suppressing Wnt signaling.	Paclitaxel	55-58	guanylate binding protein 2	Homo sapiens	0-5	
31489998-11	2020	GBP-2 upregulation could enhance the killing effect of PTX in both PTX-sensitive CRC cells and PTX-resistant CRC cells by suppressing Wnt signaling.	Paclitaxel	67-70	guanylate binding protein 2	Homo sapiens	0-5	
31489998-11	2020	GBP-2 upregulation could enhance the killing effect of PTX in both PTX-sensitive CRC cells and PTX-resistant CRC cells by suppressing Wnt signaling.	Paclitaxel	67-70	guanylate binding protein 2	Homo sapiens	0-5	
34294680-7	2021	Moreover, paclitaxel upregulates GBP2 expression, and paclitaxel-induced apoptotic activity was distinctively compromised by knockout of GBP2 in CML cells.	Paclitaxel	10-20	guanylate binding protein 2	Homo sapiens	33-37	
34294680-7	2021	Moreover, paclitaxel upregulates GBP2 expression, and paclitaxel-induced apoptotic activity was distinctively compromised by knockout of GBP2 in CML cells.	Paclitaxel	10-20	guanylate binding protein 2	Homo sapiens	137-141	
34294680-7	2021	Moreover, paclitaxel upregulates GBP2 expression, and paclitaxel-induced apoptotic activity was distinctively compromised by knockout of GBP2 in CML cells.	Paclitaxel	54-64	guanylate binding protein 2	Homo sapiens	137-141